From: A survey of evidence users about the information need of acupuncture clinical evidence
Items | Content | Respondents (n) |
---|---|---|
7.9.1 | Specify whether the included studies were RCTs and describe the method of randomization. | 10 |
7.9.2 | Specify the statistical and data processing methods, and estimate the statistical power of the data analysis. | 8 |
7.9.3 | Discuss the rationale and mechanism of action for acupuncture in modern medicine. | 7 |
7.9.4 | Describe the safety and adverse effects (both long term and short term) of acupuncture, such as epilepsy. | 7 |
7.9.5 | Provide the effect and reproducibility of acupuncture, including the description of effect evaluation time and indicators and patient outcomes. | 7 |
7.9.6 | Describe the demographic information (e.g. age, sex), physical status, medical history and conditions. | 5 |
7.9.7 | Describe the method, including study design, quality assessment, and bias control. | 4 |
7.9.8 | Describe whether the preferences and values of the patients were considered or not. | 3 |
7.9.9 | Describe the follow-up time, result, and the loss to follow-up and corresponding solutions. | 3 |
7.9.10 | Describe the origin and development of acupuncture. | 3 |
7.9.11 | Describe the status quo of research on diseases and acupuncture both at home and abroad. | 3 |
7.9.12 | Analyzing the results and presenting the discussion. | 3 |
7.9.13 | Description of the blinding method of the included studies. | 2 |
7.9.14 | Providing the references of the study. | 2 |
7.9.15 | Description of the limitations and implications of the study. | 2 |
7.9.16 | Description of the sample method and size. | 1 |
7.9.17 | Description of the innovations and strengths of the study. | 1 |
7.9.18 | Description of which type of clinical research is suitable for acupuncture. | 1 |
7.9.19 | Description of the Ethics Committee review and registration status. | 1 |
7.9.20 | Description of the conclusion of the study and the clinical evidence on acupuncture. | 1 |
7.9.21 | Declaration of the funding of the study. | 1 |
7.9.22 | Description of the environment of study implementation (such as primary health setting or one of the top three hospitals). | 1 |
7.9.23 | Description of the standard of syndrome differentiation and treatment. | 1 |